← Leaderboards
Svetlana V. Oukraintseva
Duke University
$9,881,678
Attributed
$13,087,099
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,087,099 · 5
By mechanism
R01$11,484,594 · 4
P01$1,602,505 · 1
Top collaborators
- Alexander M Kulminski9 shared
- Anatoliy I Yashin9 shared
Most similar at Duke University
Same institution · by research overlap
- Alexander M Kulminski$13,747,868
- Anatoliy I Yashin$18,815,780
- Leslie M. Collins$4,802,744
- Stephan Zuchner$30,061,220
- Donald T. Fox$5,009,082
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposTraitPathway InteractionsGeneticGenesS DiseaseAlzheimerâS Disease BiomarkerBrainGenetic VariantBiologicalLinkVariantHuman DataAgingSpecific Qualifier ValueCandidate Disease GeneResilienceAffectS Disease RiskAlzheimer Disease PreventionResistanceGenotypeHeterogeneityProxy
Grant awards (24)
Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention$638,140
R01 · FY2025 · AG · contact PI
Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention$651,163
R01 · FY2024 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$563,851
R01 · FY2024 · AG
Understanding Alzheimer's Disease in the Context of the Aging$724,888
R01 · FY2023 · AG · contact PI
Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention$568,951
R01 · FY2023 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$563,851
R01 · FY2023 · AG
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$490,438
R01 · FY2023 · AG
Understanding Alzheimer's Disease in the Context of the Aging$724,888
R01 · FY2022 · AG · contact PI
Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention$568,951
R01 · FY2022 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$564,530
R01 · FY2022 · AG
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$495,911
R01 · FY2022 · AG
Understanding Alzheimer's Disease in the Context of the Aging$724,888
R01 · FY2021 · AG · contact PI
Leveraging population-based human data to uncover mechanisms connecting Alzheimer's disease and common infections and facilitate vaccines repurposing for AD prevention$624,818
R01 · FY2021 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$564,530
R01 · FY2021 · AG
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$497,521
R01 · FY2021 · AG
Understanding Alzheimer's Disease in the Context of the Aging$724,888
R01 · FY2020 · AG · contact PI
Dissecting genetic and non-genetic heterogeneity in predisposition to Alzheimer's disease and vascular traits in pleiotropic context$564,530
R01 · FY2020 · AG
Genetics of aging, health and longevity: focus on regulatory mechanisms and functional variants connecting aging and Alzheimer's disease$502,969
R01 · FY2020 · AG
Understanding Alzheimer's Disease in the Context of the Aging$724,888
R01 · FY2019 · AG · contact PI
GENES AND OTHER FACTORS AFFECTING AGING CHANGES: EFFECTS ON HEALTH AND LIFESPAN$323,559
P01 · FY2018 · AG · contact PI
GENES AND OTHER FACTORS AFFECTING AGING CHANGES: EFFECTS ON HEALTH AND LIFESPAN$323,557
P01 · FY2017 · AG · contact PI
GENES AND OTHER FACTORS AFFECTING AGING CHANGES: EFFECTS ON HEALTH AND LIFESPAN$323,559
P01 · FY2016 · AG · contact PI
GENES AND OTHER FACTORS AFFECTING AGING CHANGES: EFFECTS ON HEALTH AND LIFESPAN$311,698
P01 · FY2015 · AG · contact PI
GENES AND OTHER FACTORS AFFECTING AGING CHANGES: EFFECTS ON HEALTH AND LIFESPAN$320,132
P01 · FY2014 · AG · contact PI